Support Reauthorization of the Special Diabetes Program
A top priority for the Endocrine Society is continuing funding for the Special Diabetes Program (SDP). SDP is actually comprised of two programs: the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and prevention programs for American Indians and Alaska Natives. Despite being a bipartisan-supported program, Congress let the Special Type 1 program expire on October 1, 2017 and provided only temporary funding for SDPI. Congress further extended funding for both programs through March 2018 as part of its end-of-year funding bill, but we want to ensure that full funding for both programs is ensure for two years.
Take Action: Urge your Senators to support full funding for the SDP today. Taking action is quick and simple. Click the "Take Action" button and provide EITHER your home address OR your email and member ID. Our software will provide you with an email you can personalize if you choose to and will direct the email to your Senators.
The SDP was created in 1997 to advance research for type 1 diabetes and to address the disproportionate burden of type 2 diabetes on American Indians and Alaska Natives (AIAN). Through this funding, the Special Type 1 Program has advanced research in islet cell transplantation, beta-cell therapy, treatment for diabetic retinopathy, and innovative therapies like the artificial pancreas. The Special Diabetes Program for Indians has also shown great success by helping AIAN prevent and manage type 2 diabetes resulting in significant reductions in A1c and amputation as well as improvements in blood pressure and kidney function. The Society has advocated for funding of these programs for a number of years and continues to urge Congress to reauthorize the SDP and to appropriate $150 million per year for these programs.